1. An insight into the risk factors of brain tumors and their therapeutic interventions.
   Sumbal Rasheed et al, 2021, Biomed Pharmacother CrossRef
2. mTOR Signaling and Potential Therapeutic Targeting in Meningioma
   Benjamin Pinker et al, 2022, IJMS CrossRef
3. Rapamycin golden jubilee and still the miraculous drug: a potent immunosuppressant, antitumor, rejuvenative agent, and potential contributor in COVID-19 treatment
   Mohamed A. Mohamed et al, 2022, Bioresour. Bioprocess. CrossRef
4. Management of Appendix Neuroendocrine Neoplasms: Insights on the Current Guidelines
   Amr Mohamed et al, 2022, Cancers CrossRef
5. Anti-ageing effects of FDA-approved medicines: a focused review
   Koranit Thanapairoje et al, 2023 CrossRef
6. Therapy in the Course of Kidney Graft Rejection—Implications for the Cardiovascular System—A Systematic Review
   Jakub Mizera et al, 2023, Life CrossRef
7. Optimization of chromatography method with mass-spectrometry detection for quantitative determination of everolimus in whool human blood of patients after heart transplantation
   E.I. Bezvulyak et al, 2023, Lab. sluzh. CrossRef
8. A phase 1 evaluation of the safety and tolerability of niraparib in combination with everolimus in advanced ovarian and breast cancers
   David Starks et al, 2023, Cancer Medicine CrossRef
9. Novel Use of Dasiglucagon, a Soluble Glucagon Analog, for the Treatment of Hyperinsulinemic Hypoglycemia Secondary to Suspected Insulinoma: A Case Report
   Dana Reynolds et al, 2023, Horm Res Paediatr CrossRef
10. Phenotypic Screening of Prospective Analgesics Among FDA‐Approved Compounds using an iPSC‐Based Model of Acute and Chronic Inflammatory Nociception
    Bryan James Black et al, 2024, Advanced Science CrossRef
11. Immunosuppressant Medications in Pregnancy
    Antonio F. Saad et al, 2024 CrossRef
12. Pulmonary Complications of Everolimus in Liver Transplant Patients: A 10-Year Experience
    Mark S Obri et al, 2024 CrossRef
13. Interferon and B-cell Signatures Inform Precision Medicine in Lupus Nephritis
    Ioannis Parodis et al, 2024, Kidney International Reports CrossRef
14. null
    , 2024, Exp Clin Transplant CrossRef
15. Oral Everolimus Following Dilation in Idiopathic Subglottic Stenosis
    Raymond J. So et al, 2024, JAMA Otolaryngol Head Neck Surg CrossRef
16. Aggressive pituitary tumors and carcinomas: medical treatment beyond temozolomide
    Dario DE ALCUBIERRE et al, 2024, Minerva Endocrinol CrossRef